Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Completed 32Unknown 13Terminated 8Recruiting 7Withdrawn 3Active not recruiting 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Infratentorial Neoplasms 1Arnold-Chiari Malformation 1Acetaminophen Exposure 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Acetaminophen × Clear all
NCT05013437 2024-04-02

AHCT

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
Plasma cell

Multiple Myeloma

NCT02911961 2021-09-02

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Denver Health and Hospital Authority

Phase 4 Withdrawn

Acetaminophen Exposure

NCT02532322 2021-04-08

Efficacy of Acetaminophen in Posterior Fossa Surgery

Children's National Research Institute

Phase 2 Withdrawn

Arnold-Chiari Malformation, Infratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡